Digital Country focus: Hungary carves out a niche in digital pharma AI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Hungary.
Views & Analysis The Simulated Cell: can a digital model aid cancer drug disc... Can a simulated cell hold the key to sky-high attrition rates between cancer drug discovery and approval?
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
